Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Filana Therapeutics (SAVA) Q3 2025 Earnings
SAVA
14
Aug
Confirmed
Q3 2024
Q1 2025
Q2 2025
Q3 2025
-0.92
-0.77
-0.63
-0.48
Details
Expected EPS
N/A
Actual EPS
-0.92
Surprise EPS
-0.92
Surprise Percent
+∞%
Description
Filana Therapeutics (SAVA) has reported earnings of -0.92 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login